CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
691-705 of 1196
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
CME/CETime Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Kendall Moseley, MD
Kenneth G. Saag, MD
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CETreatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CEEnhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
Carlos M. de Castro, MD
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
CME/CERevolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Vera Bril, MD
Nicholas J. Silvestri, MD
Hans Katzberg, MD
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
MinuteCE®Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Vera Bril, MD
Nicholas J. Silvestri, MD
- advertisement
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
CME/CETreatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Vera Bril, MD
Jonathan Strober, MD
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
MinuteCE®New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Vera Bril, MD
Nicholas J. Silvestri, MD
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
MinuteCE®Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Vera Bril, MD
Hans Katzberg, MD
Managing Side Effects in FcRn Therapy: Best Practices for gMG
MinuteCE®Managing Side Effects in FcRn Therapy: Best Practices for gMG
Vera Bril, MD
Nicholas J. Silvestri, MD
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
MinuteCE®Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Vera Bril, MD
Hans Katzberg, MD
Ocular to Generalized MG: How and Why the Disease Evolves
MinuteCE®Ocular to Generalized MG: How and Why the Disease Evolves
Vera Bril, MD
Hans Katzberg, MD
- advertisement
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
MinuteCE®Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Vera Bril, MD
Nicholas J. Silvestri, MD
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
MinuteCE®Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Vera Bril, MD
Nicholas J. Silvestri, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
MinuteCE®A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Vera Bril, MD
Nicholas J. Silvestri, MD
